Annual Revenue
$7.26 M
-$6.62 M-47.69%
December 1, 2023
Summary
- As of February 24, 2025, CSCI annual revenue is $7.26 million, with the most recent change of -$6.62 million (-47.69%) on December 1, 2023.
- During the last 3 years, CSCI annual revenue has fallen by -$4.60 million (-38.76%).
- CSCI annual revenue is now -47.69% below its all-time high of $13.88 million, reached on December 1, 2022.
Performance
CSCI Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$1.87 M
-$466.00 K-19.94%
September 1, 2024
Summary
- As of February 24, 2025, CSCI quarterly revenue is $1.87 million, with the most recent change of -$466.00 thousand (-19.94%) on September 1, 2024.
- Over the past year, CSCI quarterly revenue has stayed the same.
- CSCI quarterly revenue is now -62.15% below its all-time high of $4.94 million, reached on March 1, 2022.
Performance
CSCI Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$7.59 M
-$81.00 K-1.06%
September 1, 2024
Summary
- As of February 24, 2025, CSCI TTM revenue is $7.59 million, with the most recent change of -$81.00 thousand (-1.06%) on September 1, 2024.
- Over the past year, CSCI TTM revenue has stayed the same.
- CSCI TTM revenue is now -51.19% below its all-time high of $15.56 million, reached on June 1, 2022.
Performance
CSCI TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
CSCI Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.7% | 0.0% | 0.0% |
| 3 y3 years | -38.8% | 0.0% | 0.0% |
| 5 y5 years | -14.7% | 0.0% | 0.0% |
CSCI Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -47.7% | at low | -62.1% | +40.4% | -51.2% | +12.8% |
| 5 y | 5-year | -47.7% | at low | -62.1% | +40.4% | -51.2% | +12.8% |
| alltime | all time | -47.7% | +3123.1% | -62.1% | >+9999.0% | -51.2% | +3744.8% |
COSCIENS Biopharma Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.87 M(-19.9%) | $7.59 M(-1.1%) |
| Jun 2024 | - | $2.34 M(+13.8%) | $7.67 M(+14.0%) |
| Mar 2024 | - | $2.05 M(+54.0%) | $6.73 M(-7.3%) |
| Dec 2023 | $7.26 M(-47.7%) | $1.33 M(-31.7%) | $7.26 M(-14.2%) |
| Sep 2023 | - | $1.95 M(+40.2%) | $8.46 M(-9.2%) |
| Jun 2023 | - | $1.39 M(-46.1%) | $9.32 M(-23.6%) |
| Mar 2023 | - | $2.58 M(+1.9%) | $12.20 M(-16.2%) |
| Dec 2022 | $13.88 M(+2.9%) | $2.53 M(-9.9%) | $14.56 M(-1.8%) |
| Sep 2022 | - | $2.81 M(-34.1%) | $14.82 M(-4.7%) |
| Jun 2022 | - | $4.27 M(-13.6%) | $15.56 M(+4.8%) |
| Mar 2022 | - | $4.94 M(+76.7%) | $14.84 M(+8.9%) |
| Dec 2021 | $13.49 M(+13.7%) | $2.80 M(-21.1%) | $13.62 M(+1.6%) |
| Sep 2021 | - | $3.55 M(-0.3%) | $13.41 M(+7.6%) |
| Jun 2021 | - | $3.56 M(-4.5%) | $12.46 M(+1.1%) |
| Mar 2021 | - | $3.72 M(+44.2%) | $12.32 M(+6.1%) |
| Dec 2020 | $11.86 M(+20.3%) | $2.58 M(-0.5%) | $11.61 M(-3.0%) |
| Sep 2020 | - | $2.60 M(-24.0%) | $11.97 M(+3.5%) |
| Jun 2020 | - | $3.42 M(+13.4%) | $11.57 M(+10.4%) |
| Mar 2020 | - | $3.01 M(+2.4%) | $10.48 M(+6.3%) |
| Dec 2019 | $9.86 M(+15.8%) | $2.94 M(+33.9%) | $9.86 M(-0.6%) |
| Sep 2019 | - | $2.20 M(-5.6%) | $9.91 M(+5.9%) |
| Jun 2019 | - | $2.33 M(-2.8%) | $9.36 M(+2.7%) |
| Mar 2019 | - | $2.39 M(-20.1%) | $9.11 M(+7.5%) |
| Dec 2018 | $8.51 M(-17.2%) | $3.00 M(+82.2%) | $8.47 M(+9.6%) |
| Sep 2018 | - | $1.64 M(-20.8%) | $7.73 M(-14.0%) |
| Jun 2018 | - | $2.08 M(+18.2%) | $8.99 M(-3.9%) |
| Mar 2018 | - | $1.76 M(-22.0%) | $9.35 M(-6.3%) |
| Dec 2017 | $10.28 M(+1.0%) | $2.25 M(-22.4%) | $9.98 M(+6.8%) |
| Sep 2017 | - | $2.90 M(+18.9%) | $9.35 M(+6.9%) |
| Jun 2017 | - | $2.44 M(+2.2%) | $8.74 M(-8.2%) |
| Mar 2017 | - | $2.39 M(+47.6%) | $9.52 M(-7.2%) |
| Dec 2016 | $10.17 M(+32.3%) | $1.62 M(-29.5%) | $10.26 M(-6.2%) |
| Sep 2016 | - | $2.30 M(-28.8%) | $10.95 M(+0.0%) |
| Jun 2016 | - | $3.22 M(+2.9%) | $10.95 M(+13.0%) |
| Mar 2016 | - | $3.13 M(+36.1%) | $9.69 M(+22.5%) |
| Dec 2015 | $7.69 M(+0.4%) | $2.30 M(+0.3%) | $7.91 M(+10.6%) |
| Sep 2015 | - | $2.29 M(+16.7%) | $7.15 M(+1.5%) |
| Jun 2015 | - | $1.97 M(+45.3%) | $7.05 M(-4.3%) |
| Mar 2015 | - | $1.35 M(-12.1%) | $7.36 M(-5.3%) |
| Dec 2014 | $7.66 M(+25.0%) | $1.54 M(-29.8%) | $7.78 M(+3.7%) |
| Sep 2014 | - | $2.19 M(-3.9%) | $7.50 M(+3.5%) |
| Jun 2014 | - | $2.28 M(+28.9%) | $7.24 M(+22.2%) |
| Mar 2014 | - | $1.77 M(+40.4%) | $5.93 M(-3.4%) |
| Dec 2013 | $6.13 M(+18.0%) | $1.26 M(-35.0%) | $6.14 M(+1.5%) |
| Sep 2013 | - | $1.94 M(+101.3%) | $6.04 M(+11.7%) |
| Jun 2013 | - | $962.10 K(-51.4%) | $5.41 M(-8.5%) |
| Mar 2013 | - | $1.98 M(+69.6%) | $5.91 M(+15.3%) |
| Dec 2012 | $5.19 M(-8.4%) | $1.17 M(-10.6%) | $5.13 M(-7.6%) |
| Sep 2012 | - | $1.30 M(-11.0%) | $5.55 M(-2.7%) |
| Jun 2012 | - | $1.47 M(+22.9%) | $5.70 M(+4.4%) |
| Mar 2012 | - | $1.19 M(-24.9%) | $5.46 M(-6.6%) |
| Dec 2011 | $5.67 M(+1.6%) | $1.59 M(+8.7%) | $5.85 M(-3.7%) |
| Sep 2011 | - | $1.46 M(+19.3%) | $6.08 M(-3.1%) |
| Jun 2011 | - | $1.22 M(-22.4%) | $6.27 M(+4.3%) |
| Mar 2011 | - | $1.58 M(-13.0%) | $6.01 M(+8.0%) |
| Dec 2010 | $5.58 M | $1.81 M(+9.6%) | $5.57 M(+32.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $1.66 M(+71.3%) | $4.21 M(+12.7%) |
| Jun 2010 | - | $966.20 K(-14.7%) | $3.73 M(-2.0%) |
| Mar 2010 | - | $1.13 M(+149.4%) | $3.81 M(-1.5%) |
| Dec 2009 | $4.17 M(+20.1%) | $454.20 K(-61.5%) | $3.87 M(-0.4%) |
| Sep 2009 | - | $1.18 M(+13.1%) | $3.88 M(+10.1%) |
| Jun 2009 | - | $1.04 M(-12.2%) | $3.53 M(-9.9%) |
| Mar 2009 | - | $1.19 M(+152.4%) | $3.91 M(+10.2%) |
| Dec 2008 | $3.47 M(-0.2%) | $471.20 K(-42.8%) | $3.55 M(-8.3%) |
| Sep 2008 | - | $823.10 K(-42.4%) | $3.87 M(+6.3%) |
| Jun 2008 | - | $1.43 M(+72.8%) | $3.64 M(+11.6%) |
| Mar 2008 | - | $827.70 K(+4.6%) | $3.26 M(-0.2%) |
| Dec 2007 | $3.48 M(+22.6%) | $791.20 K(+33.0%) | $3.27 M(+9.6%) |
| Sep 2007 | - | $595.00 K(-43.4%) | $2.98 M(-2.9%) |
| Jun 2007 | - | $1.05 M(+26.1%) | $3.07 M(+7.1%) |
| Mar 2007 | - | $833.60 K(+64.9%) | $2.87 M(+2.2%) |
| Dec 2006 | $2.84 M(+22.9%) | $505.60 K(-25.9%) | $2.81 M(-0.7%) |
| Sep 2006 | - | $682.70 K(-19.5%) | $2.83 M(+4.4%) |
| Jun 2006 | - | $848.20 K(+10.0%) | $2.71 M(+0.2%) |
| Mar 2006 | - | $771.30 K(+46.6%) | $2.70 M(+20.0%) |
| Dec 2005 | $2.31 M(+41.9%) | $526.30 K(-6.5%) | $2.25 M(+10.4%) |
| Sep 2005 | - | $562.60 K(-33.2%) | $2.04 M(+16.3%) |
| Jun 2005 | - | $842.30 K(+162.2%) | $1.75 M(+19.1%) |
| Mar 2005 | - | $321.20 K(+2.5%) | $1.47 M(-6.8%) |
| Dec 2004 | $1.63 M(-4.8%) | $313.50 K(+13.3%) | $1.58 M(-10.4%) |
| Sep 2004 | - | $276.80 K(-50.6%) | $1.76 M(-4.2%) |
| Jun 2004 | - | $560.50 K(+30.9%) | $1.84 M(-1.1%) |
| Mar 2004 | - | $428.10 K(-13.9%) | $1.86 M(+10.0%) |
| Dec 2003 | $1.71 M(+81.1%) | $497.10 K(+40.7%) | $1.69 M(+22.6%) |
| Sep 2003 | - | $353.30 K(-39.3%) | $1.38 M(+10.9%) |
| Jun 2003 | - | $581.70 K(+124.9%) | $1.24 M(+13.5%) |
| Mar 2003 | - | $258.60 K(+39.6%) | $1.10 M(+13.7%) |
| Dec 2002 | $944.70 K(+30.8%) | $185.20 K(-14.8%) | $963.30 K(+2.9%) |
| Sep 2002 | - | $217.40 K(-49.9%) | $936.10 K(-5.3%) |
| Jun 2002 | - | $434.30 K(+243.6%) | $988.90 K(+35.0%) |
| Mar 2002 | - | $126.40 K(-20.0%) | $732.50 K(+0.4%) |
| Dec 2001 | $722.00 K(+33.9%) | $158.00 K(-41.5%) | $729.30 K(+23.6%) |
| Sep 2001 | - | $270.20 K(+51.9%) | $589.90 K(-8.0%) |
| Jun 2001 | - | $177.90 K(+44.4%) | $640.90 K(+7.2%) |
| Mar 2001 | - | $123.20 K(+562.4%) | $598.00 K(+10.0%) |
| Dec 2000 | $539.40 K(+139.4%) | $18.60 K(-94.2%) | $543.60 K(-0.5%) |
| Sep 2000 | - | $321.20 K(+137.9%) | $546.20 K(+27.2%) |
| Jun 2000 | - | $135.00 K(+96.2%) | $429.30 K(+18.6%) |
| Mar 2000 | - | $68.80 K(+224.5%) | $362.10 K(+0.7%) |
| Dec 1999 | $225.30 K(-13.3%) | $21.20 K(-89.6%) | $359.60 K(+6.9%) |
| Sep 1999 | - | $204.30 K(+201.3%) | $336.30 K(+70.3%) |
| Jun 1999 | - | $67.80 K(+2.3%) | $197.50 K(-50.9%) |
| Mar 1999 | - | $66.30 K(-3257.1%) | $402.00 K(-1.0%) |
| Dec 1998 | $260.00 K(-83.8%) | -$2100.00(-103.2%) | $406.10 K(-56.3%) |
| Sep 1998 | - | $65.50 K(-75.9%) | $929.60 K(-32.2%) |
| Jun 1998 | - | $272.30 K(+286.8%) | $1.37 M(-1.3%) |
| Mar 1998 | - | $70.40 K(-86.5%) | $1.39 M(-17.4%) |
| Dec 1997 | $1.61 M(+267.1%) | $521.40 K(+2.9%) | $1.68 M(+45.0%) |
| Sep 1997 | - | $506.70 K(+74.9%) | $1.16 M(+77.7%) |
| Jun 1997 | - | $289.70 K(-20.0%) | $652.00 K(+80.0%) |
| Mar 1997 | - | $362.30 K | $362.30 K |
| Dec 1996 | $437.80 K | - | - |
FAQ
- What is COSCIENS Biopharma annual revenue?
- What is the all time high annual revenue for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual revenue year-on-year change?
- What is COSCIENS Biopharma quarterly revenue?
- What is the all time high quarterly revenue for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly revenue year-on-year change?
- What is COSCIENS Biopharma TTM revenue?
- What is the all time high TTM revenue for COSCIENS Biopharma?
- What is COSCIENS Biopharma TTM revenue year-on-year change?
What is COSCIENS Biopharma annual revenue?
The current annual revenue of CSCI is $7.26 M
What is the all time high annual revenue for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual revenue is $13.88 M
What is COSCIENS Biopharma annual revenue year-on-year change?
Over the past year, CSCI annual revenue has changed by -$6.62 M (-47.69%)
What is COSCIENS Biopharma quarterly revenue?
The current quarterly revenue of CSCI is $1.87 M
What is the all time high quarterly revenue for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly revenue is $4.94 M
What is COSCIENS Biopharma quarterly revenue year-on-year change?
Over the past year, CSCI quarterly revenue has changed by $0.00 (0.00%)
What is COSCIENS Biopharma TTM revenue?
The current TTM revenue of CSCI is $7.59 M
What is the all time high TTM revenue for COSCIENS Biopharma?
COSCIENS Biopharma all-time high TTM revenue is $15.56 M
What is COSCIENS Biopharma TTM revenue year-on-year change?
Over the past year, CSCI TTM revenue has changed by $0.00 (0.00%)